The National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Biomarkers Program (PDBP) brings together multiple stakeholders dedicated to research and discovery that will advance diagnostic and progression biomarkers for Parkinson's disease.
To overcome current roadblocks to better clinical trial design through improved assessment of Parkinson's disease progression across the disease spectrum, the PDBP will focus on building resources and supporting research that promotes the discovery of PD diagnostic and progression biomarkers. Learn more
How It Works
The goal of the PDBP is to support new and existing research and resource development promoting biomarker discovery for Parkinson's disease. To achieve this goal the PDBP projects are supported through the PDBP Data Management Resource (PDBP DMR) and the NINDS Repository. Learn more